Biotech - 2/497

Entry	Author	Date	Location
Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future	Luke Timmerman	05/08/12	Seattle
San Diego’s MediciNova Nears Turning Point with Lead Drug for Asthma	Bruce V. Bigelow	05/08/12	San Diego
San Diego’s Celladon Extends Round to $53M, Opens European Office	Bruce V. Bigelow	05/08/12	San Diego
Sutro Biopharma Pulls in $16M for New Antibody Drugs	Luke Timmerman	05/08/12	San Francisco
Eleven Biotherapeutics Raises $20M to Advance Dry-Eye Drug	Arlene Weintraub	05/08/12	Boston
First Comes The $1,000 genome, Then Comes The $10,000 Analysis	Adina Mangubat	05/08/12	Seattle
Dendreon Meets Expectations with $82M in 1st Quarter Provenge Sales	Luke Timmerman	05/07/12	Seattle
Vertex Shares Boom on Cystic Fibrosis Results	Luke Timmerman	05/07/12	Boston
Antibiotic R&D is in Trouble: Here’s One Way to Fix It	Luke Timmerman	05/07/12	National
Analyst: Dendreon’s Growth Stalling With Cancer Docs as Rival Gains	Luke Timmerman	05/04/12	Seattle
NIH’s Collins Lauds “Unprecedented” Partnership at NY Bio Confab	Arlene Weintraub	05/04/12	New York
SD Life Sciences Roundup: Gen-Probe, Zogenix, & the Innovation Economy	Bruce V. Bigelow	05/03/12	San Diego
Winners of “MI 50 Companies to Watch” Awards To Be Announced	Sarah Schmid	05/03/12	Detroit
Virtual Biotech Companies: Built on Solid Bedrock or Unstable Landfill?	Stewart Lyman	05/03/12	Seattle
Genomic Health, OncoMed Team Up on Personalized Cancer Drug Work	Luke Timmerman	05/02/12	San Francisco
Boston Deals: Hologic, CustomMade, and the MIT Clean Energy Prize	Erin Kutz	05/02/12	Boston
Pfizer Takes on Genzyme With New Gaucher Drug	Arlene Weintraub	05/02/12	Boston
The Affymetrix Alumni: Where Are They Now?	Luke Timmerman	05/02/12	San Francisco
5 Things to Do Before the New Patent Law Takes Full Effect	Ted Sichelman	05/02/12	San Diego
Innovation Report Shows San Diego Added 695 Tech Jobs at End of 2011	Bruce V. Bigelow	05/01/12	San Diego
Mersana Adds $4M For Next-Generation “Armed” Cancer Drugs	Arlene Weintraub	05/01/12	Boston
Berwick’s Advice: Cost-Effectiveness Is Here to Stay	John Osborn	04/30/12	National
Hologic Buys Gen-Probe for $3.7B, Making Molecular Diagnostics Push	Luke Timmerman	04/30/12	Boston
Biotech IPOs Start to Show Some Modest Signs of Life	Luke Timmerman	04/30/12	National
Michigan State Creates Spartan Innovations to Launch Spin-Offs	Sarah Schmid	04/27/12	Detroit
Taking Open Biology to the Next Level: Notes from the Sage Congress	Stephen Friend	04/27/12	National
SD Life Sciences Roundup: Amylin, Illumina, AstraZeneca Acquires Ardea, & More	Bruce V. Bigelow	04/27/12	San Diego
UW Startups Look to Improve Bras, Bicycle Ads, Mental Health	Luke Timmerman	04/26/12	Seattle
Cardeas Gears Up for Clinic, With Drug Combo for Hospital Infections	Luke Timmerman	04/26/12	Seattle
Epizyme Gets $90M in Epigenetics Partnership with Celgene	Arlene Weintraub	04/26/12	Boston
Page 2 of 166	« previous page · next page »

Entry

Author

Date

Location

Seattle Genetics Misses 1st Quarter Sales Estimate, But Sees $1B Future

Luke Timmerman

05/08/12

Seattle

San Diego’s MediciNova Nears Turning Point with Lead Drug for Asthma

Bruce V. Bigelow

05/08/12

San Diego